Home/Quanterix/David C. Duffy, Ph.D.
DC

David C. Duffy, Ph.D.

Chief Technology Officer

Quanterix

Quanterix Pipeline

DrugIndicationPhase
LucentAD CompleteAlzheimer's Disease DetectionFDA 510(k) Submission
p-tau 205 & p-tau 212 AssaysAlzheimer's Disease ResearchResearch Use
Neurology Biomarker Portfolio (GFAP, Nf-L)Traumatic Brain Injury / NeurodegenerationClinical Research / LDT